Scientists analyzed 1781 adult Hodgkin lymphoma patients who relapsed between 2006 and 2017 after a first autologous-stem-cell- transplantation. The four-year overall survival (OS) after relapse continuously increased from 32% for patients relapsing in 2006–2008, to 63% for patients relapsing in 2015–201.7
[Leukemia]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
174052
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/